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a b s t r a c t 
Background: In aging, a host of molecular and cellular changes occur which accelerate alteration and progres- 
sion of inﬂammatory diseases. These conditions in the elderly people cause appearance of a phenomenon 
which has been denoted as “inﬂammaging”. Understanding the pathogenesis and ﬁnding new methods for 
management of inﬂammaging are essential. 
Purpose: In this paper we tried not only to explain inﬂammaging and its treatments with concentrating 
on medical plants but to collect a suﬃcient collection of anti-inﬂammatory plants with focusing on their 
mechanism of action. 
Method: In this review paper, by searching in indexing cites, desired articles were obtained since 1995 by us- 
ing keywords of inﬂammation, inﬂammaging, inﬂammation pathophysiology, free radicals and inﬂammation, 
aging inﬂammation, inﬂammatory disease, and plants or herbal medicine in inﬂammation. 
Sections: In advanced age the generation of free radicals increases in cardiovascular system. Pathological in- 
ﬂammation is also associated with production of excess free radicals More importantly, chronic inﬂammation 
makes aged people susceptible to age-related diseases. Some medicinal plants have been shown promising 
results in inhibition of inﬂammaging. Some other sections such as inﬂammation and inﬂammaging in cardio- 
vascular diseases, oxidative stress in cardiovascular complications, prevention and treatment strategies are 
presented. 
Conclusion: The results of published papers show that the symptoms of several inﬂammatory diseases can 
be inhibited or treated by active ingredients from medicinal plants. 
© 2015 Elsevier GmbH. All rights reserved. 
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The world’s population age is increasing and the aging popula-
ion is a risk factor for cardiovascular diseases (CVD). Aging generally
auses some changes which, even in absence of usual risk factors, ren-
er the cardiovascular system prone to some diseases ( Lakatta 20 0 0 ).
The progressive degeneration of the heart in elderly makes it
ore vulnerable to stress and causes an increase in cardiovascu-
ar morbidity and mortality ( Brodsky et al. 2004 ). Cardiovascular
iseases are also fuelled by some other risk factors such as di-
betes ( Baradaran et al. 2013; Behradmanesh et al. 2013 ), hyper-
ension ( Asgary et al. 2013; Ghorbani et al. 2013 ), and obesityAbbreviations: CVD, Cardiovascular diseases; NOS, Nitric oxide synthase; eNOS, En- 
othelial nitric oxide synthase; LDLox, Oxidized low density lipoprotein; NSAIDs, Non- 
teroidal anti-inﬂammatory drugs; DMARDs, Disease-modifying agents of rheumatoid 
iseases; NF-k β , Nuclear factor- kb. 
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E-mail address: raﬁeian@yahoo.com (M. Raﬁeian-Kopaei). 
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944-7113/© 2015 Elsevier GmbH. All rights reserved.  Nasri and raﬁeian-kopaei 2013; Rabiei et al. 2013a; Favarato et al.
014 ). Aging is a phenomenon resulted from genetic, epigenetic
tochastic, and environmental events in different cells and tissues.
n fact in aging, a host of molecular and cellular changes occur which
ccelerate these alterations and implicate in the progression of arte-
ial diseases ( Rabiei et al. 2013b; Favarato et al. 2014 ). Pathological
nﬂammation is also associated with production of excess free radi-
als arising predominantly from mitochondria ( Beller 2010; Raﬁeian-
opaei et al. 2012 ). There are also evidences showing that in advanced
ge the generation of free radicals increase in cardiovascular system
 Judge et al. 2005; Asadbeigi et al. 2014 ). More importantly, chronic
nﬂammation makes aged people susceptible to age-related diseases
 Franceschi et al. 20 0 0 ). 
A wide variety of diseases including diabetes ( Asadbeigi et al.
014 ) cancer ( Azadmehr et al. 2011; Nasri and raﬁeian-kopaei 2014 ),
nfection ( Bagheri 2013; Bagheri 2013 ), atherosclerosis ( Raﬁeian-
opaei et al. 2011; Raﬁeian-Kopaei et al. 2014a ), cardiovascular dis-
ases ( Khosravi-Boroujeni et al., 2013; Sarrafzadegan et al. 2013 ),
lzheimer ( Rabiei et al. 2013c, 2014 ) and other degenerative diseases
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p  ( Mardani et al. 2014; Raﬁeian-Kopaei et al. 2014b ) are associated with
increased oxidative stress and inﬂammatory conditions and are de-
graded in aging. Moreover, the process of inﬂammation is involved
in initiation and development of a wide variety of chronic diseases
( Paolisso et al. 1998 ). 
In aging the normal balance between the oxidative stress and an-
tioxidant system culminates in cardiovascular complications. These
conditions in the elderly people cause appearance of a phenomenon
which has been denoted as “inﬂammaging”. In fact, the word inﬂam-
maging is used to show inﬂammatory state in the aged individuals
( Franceschi et al. 20 0 0 ). 
Chronic inﬂammation in aging tissues “Inﬂammaging” is a perva-
sive feature of aging and most age-related diseases are associated
with inﬂammation. In fact inﬂammaging is described as systemic,
low-grade chronic inﬂammation in aged people, in absence of infec-
tion. It is a great risk factor for mortality and morbidity in the elderly
people ( Zhang et al. 2010 ). 
A mild inﬂammation is predictive of, and is associated with many
aging phenotypes. The etiology of inﬂammation in aging people and
its contribution in adverse health events is unknown. The pathways
that make us able to control inﬂammation are not fully established.
Hence, understanding the pathogenesis and ﬁnding new methods
for management of inﬂammation are beneﬁcial. This paper, there-
fore, aimed to present the recently published papers regarding in-
ﬂammation in cardiovascular diseases, focusing on the role of oxida-
tive stress. and to summarize the herbal medicines which have had
promising results in prevention and treatment of this phenomenon. 
Inﬂammation and cardiovascular disease 
Inﬂammation participates to the pathophysiology of a wide va-
riety of chronic diseases particularly injury and infectious diseases.
Interaction of various cells in the adaptive and innate immune sys-
tems with inﬂammatory mediators modulates the acute and chronic
inﬂammation causing various diseases. This coordination in inﬂam-
matory mechanisms triggers remodeling of the extracellular matrix,
oxidative stress, tissue injury, angiogenesis and ﬁbrosis in various tis-
sues. These inﬂammatory mechanisms are involved in most of cardio-
vascular complications, including coronary artery disease, ischemia,
rheumatic disease, rheumatoid arthritis, plaque disruption, thrombo-
sis and atherosclerosis. The mastery of the inﬂammatory responses
necessitates the development of new approaches to the prevention
and treatment of chronic diseases associated with aging, such as
atherosclerosis ( Libby, 2007 ). 
Although inﬂammation was previously considered as being a re-
sponse to development of atheromatous vascular damage, it is now
considered as the main causing factor in atherosclerosis rather than
being its result. In this regard, a dramatically increased risk of car-
diovascular disease has been reported in patients with pre-existing
inﬂammatory diseases. Also, patients with autoimmune disorders in-
cluding lupus erythematous and rheumatoid arthritis have higher
rates of cardiovascular diseases such as atherosclerosis ( Franceschi
et al. 20 0 0 ). Untreated infections such as periodontal disease which
cause inﬂammation are associated with increased risk of cardiovas-
cular complications ( Candore et al. 2010 ). 
The inﬂammation mediators have been shown to participate in
atheromatous changes and vascular insults. Secretion of a host of in-
ﬂammatory factors might contribute to the increased cardiovascu-
lar risks. The cardio-protective effects of many of drugs are mediated
through improvement of systemic inﬂammation. The targeted sup-
pression of various pro-inﬂammatory cascades in adipocytes speciﬁ-
cally represents an exciting new therapeutic opportunity for the car-
diovascular disease area ( Berg and Scherer 2005 ). 
The mechanisms underlying cardiovascular complications by sys-
temic inﬂammation are not established. Type 2 diabetes melli-
tus, hypercholesterolemia, atherosclerosis, hypercoagulability, andetabolic syndrome are associated with coronary vasculopathy, and
ith circulating serum factors which mediate the connections be-
ween these disease conditions. These circulating mediators are
ostly participated in systemic inﬂammation. Therefore, these fac-
ors may show the evidence for their connections with cardiovascular
athology ( Berg and Scherer 2005; Raﬁeian-Kopaei 2014 ). 
nﬂammaging and cardiovascular diseases 
The association between systemic inﬂammation and increase in
he risk of cardiovascular diseases has stimulated basic and clini-
al investigators to research for precise nature and the differences
n the nature of traditional inﬂammation and inﬂammaging in rela-
ion to cardiovascular diseases. In this regard, although their different
oles in accelerating atherogenesis remain unresolved, however, it is
nown that inﬂammatory response in elderly is not as fast as younger
ndividuals. Inﬂammation can be beneﬁcial facilitating the adapta-
ion, turnover and repair of many tissues. However, this inﬂammatory
esponse might be impaired during aging which increase the suscep-
ibility to pathogens ( Griendling and FitzGerald 2003 ). 
More importantly, in aging period, a host of molecular and cellu-
ar changes including genetic, epigenetic and environmental events
ccur which increase the progression of arterial diseases. 
In aged people, the tissues are mostly in a chronically inﬂamed
tate, with no sign of infection. The generation of free radicals also
ncreases, and makes aged people susceptible to cardiovascular dis-
ases ( Asadbeigi et al. 2014 ). 
Inﬂammaging is associated with increased levels of IL-1, IL-6, TNF
nd CRP which are independent risk factors for mortality and mor-
idity. In aging process interference occurs with anabolic signaling,
L-6 and tumor necrosis factor-a increase, down-regulating insulin
nd insulin-like growth factor-1, as well as erythropoietin signaling
nd protein synthesis. Inﬂammaging can be due to the accumulation
f damaged macromolecules and cells which increases with age due
o increased production and/or inadequate elimination. Inﬂammag-
ng might also be due to increase in harmful agents produced by mi-
roorganisms of the human body, including gut microbiota. In aging
eriod, the gut microbiota may change and the capability of the gut
o sequester these microbes and their products declines, leading to
hronic inﬂammation ( Pawelec, 1999 ). 
Increase in inﬂammation in aging also might be due to high
evel of cellular response to stress and damage (cellular senescence).
enescent cells likely fuel age-related diseases such as cardiovascular
isease, because they secrete numerous proinﬂammatory cytokines,
odifying the tissue microenvironment and altering the function of
earby normal cells. Immunosenescence also contributes to inﬂam-
aging. In aging the adaptive immunity decreases and the innate im-
unity increases resulting in mild hyperactivity, which may lead to
ocal inﬂammatory reactions in elderly people. Coagulation is con-
idered as a part of the inﬂammation system. Increase in activation of
he coagulation system in age people also can increase the inﬂamma-
ion. The higher incidence of thrombosis in the elderly has been at-
ributed to hypercoagulable state in elderly people ( Belge et al. 2002 ).
xidative stress in cardiovascular complications 
Reactive oxygen species induced oxidative stress play a cru-
ial role in development of vasculopathies, such as hypertension,
therosclerosis and restenosis after angioplasty. Although atheroscle-
osis was initially suggested to be the result of an injury to endothelial
ells and subsequent macrophage inﬁltration, however, LDL oxidation
nd its implication in formation of fatty streaks are very important in
rocess of atherogenesis ( Griendling and FitzGerald 2003 ). 
Various free radicals are produced in cardiovascular system and
lay a crucial role in vascular physiology as well as pathophysiology;
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i  he most important of them are superoxide (O 2 
. −), hydrogen perox-
de (H 2 O 2 ), peroxynitrite (ONOO 
. −) and nitric oxide (NO . ). In vascu-
ature, superoxide reacts with nitric oxide to form the highly reac-
ive molecule of peroxynitrite (ONOO.-) which has an important role
n protein nitration and lipid peroxidation. One of the most impor-
ant productions of lipid peroxidation is LDLox (Oxidized low density
ipoprotein) which has crucial role in atherogenesis ( Madihi 2013a,b ).
Nitric oxide is produced normally by endothelial nitric oxide syn-
hase (eNOS), but in process of inﬂammation, inducible NOS can also
e expressed in smooth muscle cells and macrophages ( Asgary et al.
014 ). 
Nitric oxide plays an important role in platelet aggregation. Nitric
xide which is an important mediator of endothelium-dependent va-
odilation also has a crucial role in maintaining smooth muscle cell
rowth and function ( Raﬁeian-Kopaei et al. 2014c ). 
The function of most of free radicals including superoxide and
ydrogen peroxide on cardiovascular system is critically dependent
n the amounts produced ( Raﬁeian-Kopaei et al. 2013; Nasri and
aﬁeian-Kopaei 2014 ). In low concentrations, they modulate the
unction of biochemical pathways mediating the responses such
s growth of vascular smooth muscle cells ( Raﬁeian-Kopaei et al.
013; Raﬁeian-Kopae et al. 2014d ) . However, in high concentra-
ions, free radicals can cause DNA damage and apoptosis as demon-
trated in smooth muscle and endothelial cells ( Raﬁeian-Kopaei
014; Baradaran et al. 2014 ). Pathological inﬂammation is generally
ssociated with excess free radicals and in advanced age the gener-
tion of free radicals increases, especially in cardiovascular system.
ore importantly, chronic inﬂammation makes aged people suscep-
ible to age-related diseases, including cardiovascular complications
 Franceschi et al. 20 0 0 ). 
revention and treatment strategies 
nti-inﬂammatory drugs 
When the inﬂammatory response is no longer needed, it should
e terminated to prevent unnecessary bystander damage to tis-
ues. The most important anti-inﬂammatory drugs include non-
teroidal anti-inﬂammatory drugs (NSAIDs), glucocorticoids, and
isease-modifying agents of rheumatoid diseases (DMARDs) ( Singh
012 ). NSAIDs and glucocorticoids are used in order to relieve symp-
oms, while, DMARDs are used with the aim of reducing or prevent-
ng tissue damage which are caused by inﬂammatory attack. Unfor-
unately, all of these have unacceptable side effects. Moreover, it is
ecessary to ﬁnd out drugs for very long period of times in order
o design a successful anti-inﬂammatory therapy for chronic disease.
owever, more potent anti-inﬂammatory therapy, usually has greater
hance for adverse effects to host defense. For example, increased risk
or infections are more observed in patients taking anti-TNF α therapy
 Tabas et al. 2013 ). Nowadays, more attention has been paid to medic-
nal plants with antioxidant activity. 
otential role of antioxidants 
Although free radicals are able to damage cells or its components
y oxidizing proteins or DNA or causing lipid peroxidation, but they
lso possess crucial useful physiological functions. The useful func-
ion of antioxidant systems should not be removal of free radicals en-
irely, but instead keeping oxidative stress at a level below which they
ould trigger the inﬂammatory cascade, a series of intra-nuclear and
ntra-cellular signaling which results in the release of destructive in-
ammatory cytokines ( Valko et al. 2007 ). 
Progress has been made regarding the role of the signaling cas-
ades in inﬂammatory process and early studies have also suggested
hat antioxidants might be useful in the treatment of vascular dis-
ases ( Hall Ratclife 1949 ). Studies on the effects of vegetables andruits with antioxidant activity, less or more, have suggested reduc-
ion in cardiovascular morbidity and mortality ( Verlangieri et al.
985 ), particularly in regard to ischemic heart disease ( Gey and Puska
989; Emmert and Kirchner 1999 ). 
Some studies on combinations of antioxidant drugs and vitamins
ave also had positive results. Consumption of 800 IU/day vitamin E
n patients with prevalent cardiovascular disease showed reduction
n the myocardial infarction ( Boaz et al. 20 0 0 ). 
In another study in India, combined consumption of vitamins A, C,
, and beta-carotene were protective against oxidative stress and car-
iac necrosis. They also were useful in reduction of the cardiac events
nd in preventing complications ( Singh et al. 1996 ). 
Combined supplementation with vitamins C and E reduced the
rogression of carotid atherosclerosis ( Salonen et al. 20 0 0 ). Probucol
lone or in combination with antioxidant vitamins seems to be ef-
ective in reduction of subsequent restenosis rates ( Tardif et al. 1997;
okoi et al. 1997 ). 
Most of the above mentioned studies are modest in size and in-
olved subgroups where more than one antioxidant (combinations
herapy) was used. However, in large randomized clinical trials the
esults were not all consistent with results of the above mentioned
tudies. Pooled data from over 77,0 0 0 subjects and randomized trials
f vitamin E as well as 6 trials of ß- carotene with over 131,0 0 0 partic-
pants revealed that the vitamin E was not effective and ß-carotene
onsumption was associated with a worse outcome ( P = 0 . 003). 
A large, long-term trial, on women at high risk for cardiovascu-
ar diseases reported that vitamin C, vitamin E or ß carotene had no
igniﬁcant effect on cardiovascular events ( Cook et al. 2007 ). Another
arge trial in Cambridge on the effects of vitamin C or vitamin E also
evealed no signiﬁcant reduction on the risk of major cardiovascu-
ar events ( Sesso et al. 2008 ) . Although the statistical analyses have
uggested overall signiﬁcance of antioxidant therapy in some studies,
nly those trials using probucol with or without antioxidant vitamins
howed signiﬁcant effect ( Tardif et al. 1997 ). N-Acetylcysteine, in a
rial on acute coronary syndrome, also produced signiﬁcant improve-
ent in cardiac index in patients treated with streptokinase ( Arstall
t al. 1995 ). 
Hence, there it is necessary to search for more scientiﬁc evidence
f the relative contribution of antioxidant constituents in inhibition
nd progression of cardiovascular events ( Badimon et al. 2010 ). 
nti-inﬂammatory plants 
Targeting the desired pathway through treating inﬂammation is
ot easy because of a wide range of changes in pathology as a conse-
uence of existence of many inﬂammatory mediators and pathways
n inﬂammation ( Qiuhong et al. 2013 ). 
Cyclooxygenase and lipoxygenase pathways and possibly some
ther mechanisms of initiation of inﬂammation can be eﬃciently
topped by some of the phytochemicals found in certain plants as
ell as aspirin ( Lavet et al. 2013 ). NSAIDs and corticosteroids have
n extensive use in the current treatment of inﬂammatory disor-
ers in Western medicine. Lately, phytochemicals and their anti-
nﬂammatory eﬃcacies have attracted more attention in treatment
f inﬂammation. Therefore; we tried to list and introduce some of
hese kinds of herbal drugs in this study ( Xu et al. 2007 ). 
Symptoms of several inﬂammatory diseases can be inhibited by
hinese Material Medica, such as Qijie Granule including the root
f Astragalus membranaceus, the resin of Dranaena cochinchinensis
Lour.) S.C. Chen, the root of Angelica sinensis (Oliv.), Diels, the dried
wig of Cinnamomum cassia Presl ( Zhang et al. 2004 ), the dried rattan
f Sargentodoxa cuneata (Oliv.) Rehd. etwils, the root of Rheum pal-
atum L., the resin of Commiphora myrrha Engl., the root of Paeonia
actiﬂora Pall., and the root of Glycyrrhiza uralensis Fisch, which are
roven to have acceptable curative effects in treating chronic pelvic
nﬂammation through improving the blood viscosity and regulating
1122 E. Shayganni et al. / Phytomedicine 23 (2016) 1119–1126 
Table 1 
Anti-inﬂammatory compounds of plant origin. 
Compounds Uses Mechanism of action reference 
Seeds of Phaseolus angularis Wight Anti-inﬂammation Dercreases NO, PGE2, iNOS, COX2, 
NF- κβ
(Yu et al. 2011) 
Bark of Cinnamomum cassia Blume " Decreases NO iNOS, COX2 , NF- κβ (Yu et al. 2012) 
Dried roots Asparagus cochinchinensis 
Merrill 
" Decreases MPO (Lee et al. 2009) 
Aerial of Houttuynia cordata Thunb " Decreases NO, COX2 (Li et al. 2011c) 
Roots of Scutellaria baicalensis Georgi " Decreases IL2, IL6, IL12, IL1 β , TNF- α, 
NF- κβ , I κβ
(Kim et al. 2009a) 
Aerial part of Andrographis paniculata " Decreases IL6, COX2, IL1 β , TNF- α (Parichatikanond et al. 2010) 
The fruits of Forsythia koreana Nakai " Decreases NO, iNOS, COX-2 (Lim et al. 2008) 
Dried heart wood of Caesalpinia sappan L. " Decreases NO, PGE2, iNOS, COX2 , IL-6 , 
IL1 β , TNF- α, and increases IL10 
(Wang et al. 2011) 
Corolla of Carthamus tinctorius L. " Decreases NO,PGE2,iNOS, COX2 , NO, 
iNOS TNF- α, NF- κβ
(Jun et al. 2011) 
Inﬂorescence of Chrysanthemum indicum 
Linne 
" Decreases NO,PGE2,iNOS, COX2 (Wu et al. 2011c) 
Ripe fruit of Evodia rutaecarpa " Decreases NO, iNOS (Ko et al. 2007) 
Roots of Glycyrrhiza uralensis Fisch. " Decreases NO, iNOS,IL-6, NO, NF- κβ , 
IL1 β , I κβ
(Yu et al. 2012) 
Roots of Polygala tenuifolia Willd. " Decreases NO, PGE2, iNOS, COX2 , IL1 β , 
TNF- α
(Cheng et al. 2005) 
Dried bark of Phellodendron chinense 
Schneid. 
" Decreases COX-2, IL-6 (Xian et al. 2011) 
Fruit of Vitex trifolia L. " Decreases iNOS, IL-6, IL-1 β , TNF- α and 
increases IL-10 
(Matsui et al. 2009) 
Pericarp of Zanthoxylum schinifolium Sieb. 
et Zucc 
" Decreases IL-8, TNF- α, NF- κβ , I κβ (Cheong et al. 2011) 
Roots of Angelica sinensis (Oliv.) Diels " Decreases iNOS, COX-2, IL1 β , TNF- α (Cao et al. 2009) 
Roots of Clematis chinensis Osbeck " Decreases COX-2, IL1 β , TNF- α, NF- κβ (Peng et al. 2011) 
Leaves of Plectranthus amboinicus (Lour.) 
Spreng 
" Decreases COX-2, TNF- α, NF- κβ , I κβ (Deng et al. 2011) 
Branches and leaves of Taxillus 
liquidambaricola Hosokawa 
" Decreases NO, iNOS, COX-2, TNF- α (Deng et al. 2011) 
Aerial part of Pogostemon cablin (Blanco) 
Benth 
" Decreases, IL1 β , TNF α, NO, PGE2, 
iNOS, COX2, NF- κβ
(Li et al. 2011) 
Young shoot of Aralia elata Seemann " Decreases IL1 β , TNF α, NO, PGE2, 
NF- κβ , I κβ
(Suh et al. 2007) 
Flower of Glossogyne tenuifolia Cass " Decreases PGE2, iNOS, COX-2, IL-6, 
IL-12, IL1 β , TNF- α, NF- κβ
(Wu et al. 2004) 
Dried roots of Alpinia conchigera Griff " Decreases NO, iNOS, IL1 β , TNF- α, 
NF- κβ
(Lee et al. 2006) 
Roots of Sophora alopecuroides L. " Decreases IL-6, IL1 β (Wang et al. 2012c) 
Leaves of Cistus Lourifolius Linn. (Cistaceae) Inﬂammatory ailments such 
as rheumatism and renal 
inﬂammation 
Inhibits activity of IL-1 α and PGs (Kupeli and Yesilada 2007) 
Roots of Daphne pontica Linn. 
(Thymelaeceae) 
Anti-tumor Inhibits production of PGE2 and IL-1 β (Kupeli and Yesilada 2007) 
Fruit rinds of Garcinia mangostana Linn. 
(Guttiferas; Clusiaceae) 
Treatment of trauma and 
skin infections 
Block production of iNOS and COX-2 (Chen et al. 2008) 
Fruit of Gardenia jasminoides Ellis 
(Rubiaceae) 
Treatment of inﬂammation Block production of COX-2, NF- κβ
and I κβ
(Koo et al. 2006) 
Leaves of Piper ovatum Vahl (Piperaceae) Treatment of inﬂammation Inhibitory effecr on production of 
COX-1 
(Siva et al. 2008) 
Hydroethanolic (70%) extract of 
Macrosiphonia longiﬂora 
" Decreases IL-1 β , IL-10 and NO release, 
and possibly the PGs. 
(Alberto et al. 2009) 
B. incarum, Baccharis boliviensis , Ch. 
atacamensis and P. lucida ethanolic 
extracts 
" Inhibit COX-1 and COX-2 activities ( Calle et al. 2012 ) 
J. seriphioides and P. lepidophylla extracts " Effect on COX-2 activity but not on the 
enzyme expression, 
(Torres Carro et al. 2007) 
Essential oil of Eugenia caryophyllata Nasal obstruction, 
musculoskeletal pain, 
inﬂammation 
Inhibitory effect 
on COX-2 activity (Ozturk and Ozbek 2005) 
Ethanol extracted of Desmodium 
pauciﬂorum, Mangifera indica and 
Andrographis paniculata 
Injuries Inhibition of prostoglandin synthesis (Shirani et al. 2011) 
Curcumin (a naturally-occuring yellow 
pigment present in the rhizomes of the 
plant curcuma Longa L. (Zingiberaceae)) 
Atherosclerosis, Alzheimer ´s 
disease, Arthrits and 
Pancreases 
Inhibition of lipooxigenase and COX-2 (Song et al. 2001) 
Resveratol (phytoalexin polyphenol) 
present in grape skin, red wines and 
other plants 
Anticarcinogenic and 
anti-platelet activity 
Inhibition of COX-1 and COX-2 (Jangand Pezzutto 1999) 
Flavonoids baicalein (isolated from roots of 
scutellaria baicalensis Georgi (Lamiaceae) 
Anticancer agent Inhibition of 5-LO and LTC4 and PGE2 (Middelton et al. 20 0 0) 
( continued on next page ) 
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Table 1 ( continued ) 
Compounds Uses Mechanism of action reference 
Cirsilio (isolated from achillea 
fragrantissima Forssk (Asteraceae)), 
Luteolin, morin 
Leuchemia Inhibits production of COX-2 activity (Lindolﬁ et al. 1984) 
Chrysin, apigenin and pheloretin Anti-inﬂammatory activity Inhibits COX-2 expression and platelet 
aggregation 
(Raso et al. 2001) 
Silbin, silydian and silychristin, ( from 
silybum marianum L. (Milk thistle) 
(Asteraceae) 
Anti-inﬂammatory activity Inhibit both LO and COX activity (Gupta et al. 20 0 0) 
Biﬂavon(from ginkgo biloba L. 
( ginkgoaceae) 
Arthtitic inﬂammation Inhibit PLA2 (Kim et al. 1999) 
Tectorigenin and tectoridin (isolated from 
rhizomes of belomcanda chinensis L . 
(Iridaceae)) 
Anti-inﬂammatory activity Inhibits production of COX-2 (Yamki et al. 2002) 
Platycodin D (isolated from roots of 
platycodon grandiﬂorum A. 
(campanulaceae) 
“ Inhibits production of COX-2 (Kim et al. 2001) 
Ursolic acid and oleanic acid isomers 
(extracted from plantago major L. 
(plantaginaceae) 
“ Inhibit production of COX-2 (Suh et al. 1998) 
B-tumerone and artumeron (sesquiterpens 
from Curcuma zedoaria L. 
(Zingiberaceae) 
Respiratory problems Inhibit LPS-induced PGE2 production (Hong et al. 2002) 
Fatty acids extracted from Plantago major 
L. (Plantaginaceae) 
Anti-inﬂammatory activity Inhibit both COX-A and COX-2 (Ringbom et al. 2001) 
CAPE (Caffeic acid phenetyl ester, a 
cpumpond produced by honeybees from 
the gum of various plants) 
Anti –inﬂammatory, 
anticarcinogenic, 
anti-mitogenic and 
immunomedulator 
Inhibits both COX-A and COX-2 (Michaluat et al. 1999) 
Quinazolinocarboline alkaloid rutacarpine 
(from Evodia rutaecarpa Bentham 
(Rutaceae)) 
Antithrombotic effect Inhibit LPS-induced PGE2 production, 
inhibition of TXA2 
(Woo et al. 2001) 
Aqueous and alcholic extract of Achillea 
millefolium Linn . (Asteraceae) 
Treatment of gastro- 
intestinal 
andhepato-biliary 
disorders, skin 
inﬂammasion 
Inhibition of arachidonic acid (Benedik et al. 2007) 
Aspilia africina (Pars.) (Asteraceae) Stops blood ﬂow from fresh 
wounds, traditional 
treatment of malaria 
Inhibit action of mediators like 
histamine, 5-HT, kinins and 
prostanoieds 
(Okoli et al. 2007) 
Ethanolic extract of Bacopa monnieri 
(Linn.) penn (scrophulariacceae) 
Treatment of bronchitis, 
asthma and rhumatism 
Suppres PGE1, bradykinin and 
serotonin 
(Channa et al. 2006) 
Chloroform extract of Bryonopsis Laciniosa 
(Linn.) (Cucurbitaceae) 
Anti-inﬂammatory activity 
in chronic and acute 
disease 
Inhibits increasing of ﬁbroblasts and 
synthesis of mucopolysacharids 
during formation of granuloma 
(Gupta et al. 2003) 
Neptin (isolated from dichloromethane 
extract of arial parts of Eupatorium 
arnottianum Grieseb. (Asteraceae) 
Hepatoprotective and 
against fever and 
rheumatism 
Inhibits NF- κβ activity (Okoli et al. 2007) 
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a  -lymphocytic sub groups ( Zhao et al. 2010 ). Contrasting with west-
rn drugs; boiling, steaming, treating with salt or vinegar, frying, or
harring as some speciﬁc treatments are subjecting before use of
hese plants in decoctions or in the manufacture of herbal products
 Aggarwal and Shishodia 2006 ). 
It has been shown that active ingredients from medicinal plants
lay a signiﬁcant part in the prevention and treatment of inﬂam-
atory diseases ( Schepetkin and Quinn 2006 ). A characteristic of
edicinal plants is their unique structural diversity and wide-ranging
f pharmacological effects in contrast with common synthetic anti-
nﬂammatory drugs ( Qiuhong et al. 2013 ). 
Recently, polysaccharides, which are widely used in the biomed-
cal ﬁeld as a result of their therapeutic effects and relatively low
oxicity ( He et al. 2012 ), are screened for their anti-inﬂammatory
ctivities based on their unique structures in herbal plants. For ex-
mple, it has been revealed that the main component of Astragalus
embranaceus Bunge and Astragalus polysaccharides, have anti-
nﬂammatory ability involving the inhibition of TNF- α and IL-1 β and
eduction of nuclear factor- kb (NF-k β) activity ( Quang et al. 2012 ).
he challenging part of using the polysaccharide drugs is the diﬃ-
ulty of targeting a speciﬁc location not only because of their large
olecular weight but also due to their easy digestion and oral degra-ation by oral delivery. Hence, it seems that it is essential to set
p the smallest effective parts of the structure and a useful form
f direction for anti-inﬂammatory polysaccharides in further studies
 Mendes et al. 2012 ). 
It has been reported that essential oils of some medicinal plants
ave signiﬁcant anti-inﬂammatory activities ( Dunga et al. 2009 ). For
xample, secretion of pro-inﬂammatory cytokines such as TNF- α, IL-
 β , and NF- κβ in RAW264.7 cells, a mouse macrophage-like cell line,
hat are induced by lipopolysaccharide (LPS) can be obviously pre-
ented by applying the essential oil of the buds of Cleistocalyx op-
rculatus (Roxb.) Merret Perry. Additionally, this oil can suppress the
uclear translocation of the p65 subunit and has the ability of inhibit-
ng a phorbolester- induced which caused ear swelling and the water
ontent of the skin in BALB/c mice ( Lin et al. 1997 ). All together, these
esults suggest the anti-inﬂammatory effect of these essential oil ex-
racts by suppressing the expression of pro-inﬂammatory cytokines. 
It is proven that alkaloids are the main bioactive components in
nti-inﬂammatory treatments, such as matrine. Matrine is extracted
rom the root of Sophora ﬂavescens Ait, in order to use in treat-
ent of some inﬂammatory diseases, such as enteritis, hepatitis and
topic dermatitis by inhibiting the activation of inﬂammatory signal
nd also, expression of pro-inﬂammatory mediators in human skin
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 keratinocytes, ﬁbroblasts, Kupffer cells, and rat intestinal micro-
vascular endothelial cells ( Liu et al. 2007; Zhang et al. 2008; Cheng
et al. 2009; Zhang et al. 2011 ). Moreover, it has been found that
the alkaloid, matrine, can reduce the increased levels of TNF- α, IL-
6 and HMG β1 induced by LPS, in both in vivo and in vitro situations
( Havsteen 1983 ) (see the table). 
Citrus fruits, tea and wine are good sources for a wide range of
bioﬂavonoids, with the ability of reducing inﬂammation by inhibit-
ing cyclooxygenase and lipoxygenase pathways ( Heim et al. 2002 ).
Flavonoids, are one of the important members in anti-inﬂammatory
components category, with a large family of compounds which repre-
sent varied biological properties and having the ability of suppressing
the expression of inﬂammatory proteins and cytokines ( Hu and Kitts
2003; Kim et al. 2004 ). Flavanoieds have been used in the form of
crude plant extracts for their anti-inﬂammatory effects. For example,
it has been conﬁrmed that ﬂavonoids are the major bioactive ﬂavones
in Radix Scutellariae (the root of Scutellariae baicalensis Georgi.),
existing in the forms of aglycones (baicalein, wogonin, oroxylin A)
and glycosides, which are used for the treatment of inﬂammatory
diseases. 
Luteolin, 3 ′ ,4 ′ -dihydroxyﬂavone, galangin, morin and apigenin
as some examples of ﬂavonoieds are proven to be inhibitors of
COX, whereas some ﬂavones/ ﬂavonols/isoﬂavones, mainly ﬂavones,
signiﬁcantly inhibit production of NO, as well ( Abad-Martinez
et al. 2005 ). Some of these compounds have been previously
isolated and identiﬁed in B. incarum, B. boliviensis and P. lu-
cida ( Zampini et al. 2008; Calle et al. 2012; D’Almeida et al.
2013 ). D’Almeida et al. demonstrated that P. lucida extract inhibits
arachidonic acid metabolism via several enzymes (COX, LOX and
phospholipase A2). 
Steroidal saponins are naturally found in the roots and barks of
various Chinese herbs, which possess anti- inﬂammatory effects, such
as: anemar saponin B, a steroidal saponin which are isolated from
the rhizomes of Anemarrhena asphodeloides Bge by decreasing the
protein and mRNA levels of iNOS and COX-2. Similar to ﬂavonoids,
steroidal saponins decrease the expression and production of pro-
inﬂammatory cytokines, as well as TNF- α and IL-6. Additionally, the
p65 subunit of NF-kB is obviously inhibited by phosphorylation of in-
hibitory kappa β-a ( Qiuhong et al. 2013 ). 
Phenyl-propanoids are important components of the anti-
inﬂammatory plants. Honokiol, as a member of phenyl propanoid
component can be isolated from the herb Magnolia oﬃcinalis Rehd.
etwils. ( Qiuhong et al. 2013 ). It seems that saponins act as therapeutic
agents on atherosclerosis by their anti-inﬂammatory activity, involv-
ing NF-k β signaling pathway ( Qiuhong et al. 2013 ). Table 1 shows the
anti-inﬂammatory compounds of plant origin with their mechanisms
actions. 
Conclusion 
Inﬂammation is an acute or chronic process and a defense re-
sponse to injury, autoimmune response, tissue ischemia or infectious
agents. Acute inﬂammation is a primary defense against injury or
infection and a suitable stimulus factor in the healing process. It is
usually beneﬁcial, starts quickly, and then becomes severe. Chronic
inﬂammation, occurring after acute inﬂammation, is not favorable to
the system. Chronic inﬂammation has signiﬁcant role in most of the
chronic disease such as diabetes mellitus, atherosclerosis, Crohn’s
disease, cancer, ulcerative colitis and CNS disorders, which have
brieﬂy discussed in the present study. 
Obviously, chronic diseases involve very suffering ones, so that
it has been tried to ﬁnd drugs with low side effects in order to de-
sign a successful anti-inﬂammatory therapy for. Medical plants can
be applied because of their structural diversity and wide-ranging
of pharmacological effects in contrast with common synthetic anti-
inﬂammatory drugs. One of the good strategies that can be suf-ciently used is extracting or isolating components from medical
lants in order to develop anti-inﬂammatory drugs. It should be note
hat the pathological inﬂammation is associated with production of
xcess free radicals and medicinal plants mostly counteract oxidative
tress by reducing free radicals ( Asadi-Samani et al. 2014; Bahmani
t al. 2014 ). Therefore, isolation of anti-inﬂammatory compounds
ay not be associated with antioxidant activity. 
At the present study, we tried to not only explain inﬂammation,
isease and its treatments with concentration on medical plants but
ollected a suﬃcient collection of anti-inﬂammatory plants with fo-
using on their mechanism of action. But as far as the huge number
f existent herbs around the world collecting all together seems to be
mpossible. 
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